Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jonathan Mark Davis

TitleAsst Professor-Research
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-BioChem&Molecular Genetics
Phone720/942-1805

    Collapse Research 
    Collapse research activities and funding
    R01HL064158     (DAVIS, JONATHAN M.)Jul 1, 2000 - Jun 30, 2006
    NIH/NHLBI
    DELIVERY OF ANTIOXIDANT ENZYMES &GENES TO NEONATAL LUNG
    Role: Principal Investigator

    R01DA032889     (DAVIS, JONATHAN M.)Sep 1, 2012 - Jun 30, 2016
    NIH/NIDA
    Improving Outcome in Neonatal Abstinence Syndrome
    Role: Principal Investigator

    R01FD003899     (DAVIS, JONATHAN M.)Jul 15, 2013 - Aug 31, 2017
    FDA
    Phase 2 Study of rhCC10 to Prevent Neonatal Bronchopulmonary Dysplasia
    Role: Principal Investigator

    R21DA041706     (DAVIS, JONATHAN M.)Aug 1, 2016 - Jul 31, 2018
    NIH/NIDA
    Establishing Risk in Neonatal Abstinence Syndrome
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cole FS, Wegner DJ, Davis JM. The Genomics of Neonatal Abstinence Syndrome. Front Pediatr. 2017; 5:176. PMID: 28879171.
      View in: PubMed
    2. Bull SS, Brooks-Russell A, Davis JM, Roppolo R, Corsi K. Awareness, Perception of Risk and Behaviors Related to Retail Marijuana Among a Sample of Colorado Youth. J Community Health. 2017 Apr; 42(2):278-286. PMID: 27639866.
      View in: PubMed
    3. Davis JM, Suleta K, Corsi KF, Booth RE. A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO. AIDS Behav. 2017 Apr; 21(4):1044-1053. PMID: 28063072.
      View in: PubMed
    4. Davis JM, Suleta KA, Booth RE. Response to Letter to the Editor: Marijuana Legalization and Increased Seeking of Care. Am J Prev Med. 2017 Mar; 52(3):e93. PMID: 28215274.
      View in: PubMed
    5. Booth RE, Davis JM, Dvoryak S, Brewster JT, Lisovska O, Strathdee SA, Latkin CA. HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial. Lancet HIV. 2016 Oct; 3(10):e482-9. PMID: 27658879.
      View in: PubMed
    6. Stover MW, Davis JM. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol. 2015 Nov; 39(7):561-5. PMID: 26452318; PMCID: PMC4628571 [Available on 11/01/16].
    7. Davis JM, Mendelson B, Berkes JJ, Suleta K, Corsi KF, Booth RE. Public Health Effects of Medical Marijuana Legalization in Colorado. Am J Prev Med. 2016 Mar; 50(3):373-379. PMID: 26385161; PMCID: PMC4762755 [Available on 03/01/17].
    8. Wachman EM, Hayes MJ, Sherva R, Brown MS, Davis JM, Farrer LA, Nielsen DA. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend. 2015 Oct 01; 155:253-9. PMID: 26233486; PMCID: PMC4581974 [Available on 10/01/16].
    9. Davis JM, Searles VB, Anderson N, Keeney J, Dumas L, Sikela JM. DUF1220 dosage is linearly associated with increasing severity of the three primary symptoms of autism. PLoS Genet. 2014 Mar; 10(3):e1004241. PMID: 24651471; PMCID: PMC3961203.
    10. Davis JM, Searles VB, Severtson SG, Dart RC, Bucher-Bartelson B. Seasonal variation in suicidal behavior with prescription opioid medication. J Affect Disord. 2014 Apr; 158:30-6. PMID: 24655762.
      View in: PubMed
    11. Davis JM, Severtson SG, Bucher-Bartelson B, Dart RC. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):18-25. PMID: 24130046.
      View in: PubMed
    12. Davis JM, Keeney JG, Sikela JM, Hepburn S. Mode of genetic inheritance modifies the association of head circumference and autism-related symptoms: a cross-sectional study. PLoS One. 2013; 8(9):e74940. PMID: 24058641; PMCID: PMC3776732.
    13. Severtson SG, Bartelson BB, Davis JM, Muñoz A, Schneider MF, Chilcoat H, Coplan PM, Surratt H, Dart RC. Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain. 2013 Oct; 14(10):1122-30. PMID: 23816949.
      View in: PubMed
    14. Afolayan AJ, Eis A, Teng RJ, Bakhutashvili I, Kaul S, Davis JM, Konduri GG. Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol. 2012 Nov 15; 303(10):L870-9. PMID: 22962015; PMCID: PMC3517675.
    15. Dumas LJ, O'Bleness MS, Davis JM, Dickens CM, Anderson N, Keeney JG, Jackson J, Sikela M, Raznahan A, Giedd J, Rapoport J, Nagamani SS, Erez A, Brunetti-Pierri N, Sugalski R, Lupski JR, Fingerlin T, Cheung SW, Sikela JM. DUF1220-domain copy number implicated in human brain-size pathology and evolution. Am J Hum Genet. 2012 Sep 07; 91(3):444-54. PMID: 22901949; PMCID: PMC3511999.
    16. Dasgupta N, Davis J, Jonsson Funk M, Dart R. Using poison center exposure calls to predict methadone poisoning deaths. PLoS One. 2012; 7(7):e41181. PMID: 22829925; PMCID: PMC3400615.
    17. Parad RB, Allred EN, Rosenfeld WN, Davis JM. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase. Neonatology. 2012; 102(2):139-44. PMID: 22710821.
      View in: PubMed
    18. Farrow KN, Lakshminrusimha S, Czech L, Groh BS, Gugino SF, Davis JM, Russell JA, Steinhorn RH. SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2010 Jul; 299(1):L109-16. PMID: 20400523; PMCID: PMC2904095.
    19. DiGuiseppi C, Hepburn S, Davis JM, Fidler DJ, Hartway S, Lee NR, Miller L, Ruttenber M, Robinson C. Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics. J Dev Behav Pediatr. 2010 Apr; 31(3):181-91. PMID: 20375732; PMCID: PMC4419691.
    20. Farrow KN, Lakshminrusimha S, Reda WJ, Wedgwood S, Czech L, Gugino SF, Davis JM, Russell JA, Steinhorn RH. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2008 Dec; 295(6):L979-87. PMID: 18790993; PMCID: PMC2604791.
    21. Lakshminrusimha S, Russell JA, Wedgwood S, Gugino SF, Kazzaz JA, Davis JM, Steinhorn RH. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2006 Dec 15; 174(12):1370-7. PMID: 17008638; PMCID: PMC2111046.
    22. Brunelli L, Hamilton E, Davis JM, Koo HC, Joseph A, Kazzaz JA, Wolfson MR, Shaffer TH. Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits. Pediatr Res. 2006 Jul; 60(1):65-70. PMID: 16690961.
      View in: PubMed
    23. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics. 2006 Mar; 117(3 Pt 2):S52-6. PMID: 16777823.
      View in: PubMed
    24. Kinsella JP, Parker TA, Davis JM, Abman SH. Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med. 2005 Sep 15; 172(6):745-9. PMID: 15947289; PMCID: PMC2718553.
    25. Koo HC, Davis JM, Li Y, Hatzis D, Opsimos H, Pollack S, Strayer MS, Ballard PL, Kazzaz JA. Effects of transgene expression of superoxide dismutase and glutathione peroxidase on pulmonary epithelial cell growth in hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2005 Apr; 288(4):L718-26. PMID: 15579623.
      View in: PubMed
    26. Veloira WG, Domenico P, LiPuma JJ, Davis JM, Gurzenda E, Kazzaz JA. In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex. J Antimicrob Chemother. 2003 Dec; 52(6):915-9. PMID: 14585856.
      View in: PubMed
    27. Chandra S, Davis JM, Drexler S, Kowalewska J, Chester D, Koo HC, Pollack S, Welch R, Pilon A, Levine CR. Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. Pediatr Res. 2003 Oct; 54(4):509-15. PMID: 12815115.
      View in: PubMed
    28. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics. 2003 Mar; 111(3):469-76. PMID: 12612223.
      View in: PubMed
    29. Levine CR, Kazzaz JA, Koo HC, Chester D, Merritt TA, Matalon S, Pollack S, Davis JM. Effects of variable concentrations of inhaled nitric oxide and oxygen on the lungs of newborn piglets. Pediatr Pulmonol. 2002 Jul; 34(1):58-65. PMID: 12112799.
      View in: PubMed
    30. Davis JM. Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr Suppl. 2002; 91(437):23-5. PMID: 12200893.
      View in: PubMed
    31. Foust R, Cox C, Davis JM, Wolfson MR, Miller TF, Horowitz S, Shaffer TH. Pulmonary antioxidant enzyme activity during early development: Effect of ventilation. Pediatr Crit Care Med. 2001 Jan; 2(1):63-68. PMID: 12797891.
      View in: PubMed
    Davis's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)